Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in the Remission of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in the Remission of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Published:2024-01-15 Issue:3 Volume:96 Page:69-82
ISSN:0032-373X
Container-title:Polish Journal of Surgery
language:
Short-container-title:Pol Przegl Chir

Author:

Aguirre Talledo Joanna¹^ORCID,Caballero-Alvarado Jose²^ORCID,De la Cruz Davila Maria¹^ORCID,Zavaleta-Corvera Carlos¹^ORCID

Affiliation:

1. School of Medicine, Antenor Orrego Private University, Trujillo, Peru

2. School of Medicine, Antenor Orrego Private University, Trujillo, Peru, Surgery Department, Regional Hospital of Trujillo, Trujillo, Peru

Abstract

Introduction: Obesity's associated comorbidities and treatment costs have risen significantly, highlighting the importance of early weight loss strategies. Bariatric surgeries like Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) have been effective in promoting weight loss and improving type 2 diabetes mellitus (T2DM) management. Aim: The aim was to determine whether Roux-en-Y gastric bypass is more effective than vertical sleeve gastrectomy in the remission of type 2 diabetes mellitus (T2DM). Methods: A systematic review and meta-analysis was performed. A literature search was performed in the databases Web of Science, Medline/PubMed, Embase, Scopus, and Medline/Ovid. A total of 1323 results were identified; after screening, 14 articles were selected and included in the systematic review. Primary and secondary outcomes were measured by RR with a 95% CI. Results: The primary outcome of T2DM remission was 15% in favor of VSG (RR: 1.15, [95% CI: 1.04–1.28]). For secondary outcomes, hypertension remission was 7% in favor of VSG (RR: 1.07, [95% CI: 1.00–1.16]). Remission of dyslipidemia was 16% in favor of VSG (RR: 1.16, [95% CI: 1.06–1.26]). BMI after surgery was in favor of RYGB (MD: –1.31, [95% CI: –1.98 to –0.64]). For weight loss, the results favored VSG (MD: 6.50, [95% CI: 4.99–8.01]). In relation to total cholesterol, they were 65% favorable for RYGB (MD: –0.35, [95% CI: –0.46 to –0.24]), with a value of p <0.05. For LDL values, our results were 69% favorable for RYGB (MD: –0.31, [95% CI: –0.45 to –0.16]), p <0.01 value. Conclusions: Laparoscopic sleeve gastrectomy is more effective in T2DM remission, hypertension remission, dyslipidemia remission, and weight loss compared to Roux-en-Y gastric bypass. Roux-en-Y gastric bypass is more effective at lowering BMI, total cholesterol, LDL, and TG compared to laparoscopic sleeve gastrectomy.

Publisher

Index Copernicus

Link

https://ppch.pl/gicid/pdf/01.3001.0054.2674

Reference43 articles.

1. Flegal K.M., Kruszon-Moran D., Carroll M.D., Fryar C.D., Ogden C.L.: Trendsin Obesity Among Adults in the United States, 2005 to 2014. JAMA., 2016;315(21): 2284.

2. Hales C.M., Fryar C.D., Carroll M.D. et al.: Differences in Obesity Prevalenceby Demographic Characteristics and Urbanization Level Among Adults in theUnited States, 2013–2016. JAMA., 2018; 319(23): 2419.

3. Villena Chávez J.E.: Prevalencia de sobrepeso y obesidad en el Perú. Rev PeruGinecol Obs., 2017; 63: 593–598.

4. Bhadoria A., Sahoo K., Sahoo B. et al.: Childhood obesity: Causes and consequences.J Fam Med Primary Care., 2015; 4(2): 187.

5. Climent E., Benaiges D., Goday A. et al.: Obesidad mórbida y dislipemia: impactode la cirugía bariátrica. Clin. Investig. Arterioscler., 2020; 32(2): 79–86.